A retrospective real-world study to assess clinical and biochemical predictive factors in advanced gastric cancer receiving ramucirumab therapy
Latest Information Update: 14 Oct 2020
At a glance
- Drugs Paclitaxel (Primary) ; Ramucirumab (Primary)
- Indications Gastric cancer
- Focus Pharmacodynamics
- 14 Oct 2020 New trial record
- 21 Sep 2020 Results presented at the 45th European Society for Medical Oncology Congress